Carbapenem-based Antibiotics Market (2022 - 2032)
Carbapenem-based Antibiotics Market Size, Trend Analysis & Competition Tracking By Product Type (Meropenem, Ertapenem, Panipenem, Tebipenem), By Indication (Intra-abdominal Infections, Bacterial Meningitis, Skin and Skin Structure Infections, Acute Pelvic Infections) - Global Market Insights 2021 to 2031
Core Findings
FREE CustomizationCarbapenem-based Antibiotics Market to Register Strong Growth, on Back of Increasing Incidence of Hospital Acquired Pneumonia and Bacterial Infections
Incidence of bacterial infections is increasing rapidly across the world offering significant revenue generating opportunities for the carbapenem-based antibiotics market. Pneumonia acquired in hospital settings due to longer patient stays, is often difficult to treat and exists as the comorbidity to various chronic diseases such as cancer, organ transplant. etc. It also interferes with the disease treatment and may be fatal if not treated with broad-spectrum antibiotics such as carbapenem-based antibiotics.
As per the Center for Disease Control (CDC), people admitted to hospital settings due to various reasons such as immunosuppressive treatment and inappropriately followed infection control protocol, suffer from hospital-acquired pneumonia (HAP). Along with HAP, incidence of various bacterial diseases is increasing rapidly, which in turn is expected to drive the growth of the carbapenem-based antibiotics market.
Surgery-Associated Bacterial Infection to Boost Demand for Carbapenem-Based Antibiotics
Some forms of chronic diseases often require open surgery as a treatment protocol. Before performing open surgery, carbapenem-based antibiotics are often administered as the prophylactic measure for the prevention of surgery-related bacterial infections.
The World Health Organization also emphasizes on infection control protocol i.e. prophylactic administration of the carbapenem-based antibiotics that can limit or eliminate the chances of surgery-associated bacterial infection. As per WHO, 30% of global disease burden is accruing to surgery related diseases pointing towards a heightened demand for prophylactic, carbapenem-based antibiotics.
Carbapenem-based Antibiotics Market Gains Traction, with Generic Alternatives to Ertapenem to be Lucrative Revenue Pockets
Ertapenem is one of the most widely used carbapenem-based antibiotics and its patent expired in November 2017. Various regional as well as global pharmaceutical companies are assessing feasibility for possible re- launch of generic version of ertapenem in various regions.
For instance, in June 2018, Aurobindo Pharma received FDA approval for generic Invanz injection. Invanz is Merck Sharp and Dohme Corp.’s joint carbapenem-based antibiotic product for the treatment of various bacterial infections. The launch of various generic version of carbapenem-based antibiotics such as ertapenem in regions such as North America and Europe is expected to offer substantial revenue generation opportunities.
Lower price of generic carbapenem-based antibiotics is expected to result in increased product adoption, thus compelling carbapenem-based antibiotic manufacturers to enhance geographical footprint in lower- and middle-income countries. Increasing supply-chain operations in regions such as North America, East Asia and Europe will further give impetus to high revenue generating carbapenem-based antibiotics markets.
Competitive Landscape
- Pfizer Inc.
- Merck Co. & Inc.
- Sumitomo Dainippon Pharma Co., Ltd.
are top players operating in the carbapenem-based antibiotics market. The top three players contributed more than 92% revenue share in the carbapenem-based antibiotics market in 2018.
Key players are prominently focusing on increasing their carbapenem-based antibiotics availability in different countries for the treatment of a large patient pool with bacterial infections.
Key Segments of Carbapenem-based Antibiotics Market
Fact.MR’s study on the carbapenem-based antibiotics therapy market offers information divided into four important segments - product, indication, sales channel, and region. This report offers comprehensive data and information about the important market dynamics, and growth parameters associated with these categories.
-
By Product Type :
- Meropenem
- Ertapenem
- Imipenem
- Doripenem
- Panipenem
- Tebipenem
-
By Indication :
- Intra-abdominal Infections
- Urinary Tract Infections
- Pneumonia
- Bacterial Meningitis
- Skin and Skin Structure Infections
- Acute Pelvic Infections
- Prophylaxis of Surgical Site Infection
- Respiratory Tract Infections
- Gynaecologic Infections
- Endocarditis
- Others
-
By Sales Channel :
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
-
By Region :
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Global Market Demand (in Value or Size in US$ Mn) Analysis 2014 to 2018 and Forecast, 2019 to 2029
- 6. Market Background
- 7. Global Market Analysis 2014 to 2018 and Forecast 2019 to 2029, by Product Type
- 7.1. Meropenem
- 7.2. Ertapenem
- 7.3. Imipenem
- 7.4. Doripenem
- 7.5. Panipenem
- 7.6. Tebipenem
- 8. Global Market Analysis 2014 to 2018 and Forecast 2019 to 2029, by Indication
- 8.1. Intra-abdominal Infections
- 8.2. Urinary Tract Infections
- 8.3. Pneumonia
- 8.4. Bacterial Meningitis
- 8.5. Skin and Skin Structure Infections
- 8.6. Acute Pelvic Infections
- 8.7. Prophylaxis of Surgical Site Infection
- 8.8. Respiratory Tract Infections
- 8.9. Gynaecologic Infections
- 8.10. Endocarditis
- 8.11. Others
- 9. Global Market Analysis 2014 to 2018 and Forecast 2019 to 2029, by Sales Channel
- 9.1. Hospital Pharmacies
- 9.2. Retail Pharmacies & Drug Stores
- 9.3. Online Pharmacies
- 10. Global Market Analysis 2014 to 2018 and Forecast 2019 to 2029, by Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Europe
- 10.4. East Asia
- 10.5. South Asia
- 10.6. Oceania
- 10.7. Middle East and Africa (MEA)
- 11. North America Market Analysis 2014 to 2018 and Forecast 2019 to 2029
- 12. Latin America Market Analysis 2014 to 2018 and Forecast 2019 to 2029
- 13. Europe Market Analysis 2014 to 2018 and Forecast 2019 to 2029
- 14. South Asia Market Analysis 2014 to 2018 and Forecast 2019 to 2029
- 15. East Asia Market Analysis 2014 to 2018 and Forecast 2019 to 2029
- 16. Oceania Market Analysis 2014 to 2018 and Forecast 2019 to 2029
- 17. Middle East and Africa Market Analysis 2014 to 2018 and Forecast 2019 to 2029
- 18. Market Structure Analysis
- 19. Competition Analysis
- 19.1. ACS Dobfar S.p.A.
- 19.2. Amneal Pharmaceuticals LLC
- 19.3. Apotex, Inc.
- 19.4. Aurobindo Pharma Ltd.
- 19.5. Daewoong Pharmaceutical Co., Ltd.
- 19.6. Fedora Pharmaceuticals, Inc.
- 19.7. Gland Pharma Ltd. (Fosun Pharmaceutical Co., Ltd.)
- 19.8. Iterum Therapeutics plc
- 19.9. Jeil Pharmaceutical Co., Ltd.
- 19.10. Johnson & Johnson Pharmaceuticals
- 19.11. Meiji Seika Pharma Co., Ltd.
- 19.12. Merck & Co., Inc.
- 19.13. Pfizer, Inc.
- 19.14. Savior Lifetec Corporation
- 19.15. Spero Therapeutics, Inc.
- 19.16. Sumitomo Dainippon Pharma Co., Ltd.
- 20. Assumptions and Acronyms Used
- 21. Research Methodology
List Of Table
Table 01: Global Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Region
Table 02: Global Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Product Type
Table 03: Global Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Indication
Table 04: Global Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Sales Channel
Table 05: North America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 06: North America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Product Type
Table 07: North America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Indication
Table 08: North America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Sales Channel
Table 09: Latin America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 10: Latin America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Product Type
Table 11: Latin America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Indication
Table 12: Latin America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Sales Channel
Table 13: Europe Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 14: Europe Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Product Type
Table 15: Europe Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Indication
Table 16: Europe Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Sales Channel
Table 17: South Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 18: South Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Product Type
Table 19: South Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Indication
Table 20: South Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Sales Channel
Table 21: East Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 22: East Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Product Type
Table 23: East Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Indication
Table 24: East Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Sales Channel
Table 25: Oceania Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 26: Oceania Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Product Type
Table 27: Oceania Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Indication
Table 28: Oceania Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Sales Channel
Table 29: MEA Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 30: MEA Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Product Type
Table 31: MEA Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Indication
Table 32: MEA Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Sales Channel
Table 33: Emerging countries Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By region
Table 34: China Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Product Type
Table 35: China Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Indication
Table 36: China Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Sales Channel
Table 37: India Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Product Type
Table 38: India Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Indication
Table 39: India Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Sales Channel
Table 40: Brazil Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Product Type
Table 41: Brazil Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Indication
Table 42: Brazil Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Sales Channel
List Of Figures
Figure 01: Global Market Value Analysis and Forecast, 2017 to 2029 (US$ Mn)
Figure 02: Global Market Value Opportunity Assessment, 2019 to 2029
Figure 03: Global Revenue Share by Region, 2019E and 2029F
Figure 04: Global Market Attractiveness Analysis, By Region, 2019E
Figure 05: Global Revenue Share (in US$ Mn) by Product Type, 2019E and 2029F
Figure 06: Global Market Attractiveness Analysis, By Product Type, 2019E
Figure 07: Global Revenue Share by Indication, 2019E and 2029F
Figure 08: Global Market Attractiveness Analysis, By Indication, 2019E
Figure 09: Global Revenue Share by Sales Channel, 2019E and 2029F
Figure 10: Global Market Attractiveness Analysis, By Sales Channel, 2019E
Figure 11: North America Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 12: North America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 13: North America Market Value Share 2019E, By Product Type
Figure 14: North America Market Value Share 2019E, By Indication
Figure 15: North America Market Value Share 2019E, By Sales Channel
Figure 16: North America Market Value Share 2019E, By Country
Figure 17: North America Market Value Share Analysis 2019E & 2029F, By Country
Figure 18: North America Market Attractiveness Analysis, By Country
Figure 19: North America Market Value Share Analysis, 2019E & 2029F, By Product Type
Figure 20: North America Market Attractiveness Analysis, By Product Type
Figure 21: North America Market Value Share Analysis 2019E & 2029F, By Indication
Figure 22: North America Market Attractiveness Analysis, By Indication
Figure 23: North America Market Value Share Analysis, 2019E & 2029F, By Sales Channel
Figure 24: North America Market Attractiveness Analysis, By Sales Channel
Figure 25: Latin America Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 26: Latin America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 27: Latin America Market Value Share 2019E, By Product Type
Figure 28: Latin America Market Value Share 2019E, By Indication
Figure 29: Latin America Market Value Share 2019E, By Sales Channel
Figure 30: Latin America Market Value Share 2019E, By Country
Figure 31: Latin America Market Value Share Analysis 2019E & 2029F, By Country
Figure 32: Latin America Market Attractiveness Analysis, By Country
Figure 33: Latin America Market Value Share Analysis, 2019E & 2029F, By Product Type
Figure 34: Latin America Market Attractiveness Analysis, By Product Type
Figure 35: Latin America Market Value Share Analysis 2019E & 2029F, By Indication
Figure 36: Latin America Market Attractiveness Analysis, By Indication
Figure 37: Latin America Market Value Share Analysis, 2019E & 2029F, By Sales Channel
Figure 38: Latin America Market Attractiveness Analysis, By Sales Channel
Figure 39: Europe Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 40: Europe Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 41: Europe Market Value Share 2019E, By Product Type
Figure 42: Europe Market Value Share 2019E, By Indication
Figure 43: Europe Market Value Share 2019E, By Sales Channel
Figure 44: Europe Market Value Share 2019E, By Country
Figure 45: Europe Market Value Share Analysis 2019E & 2029F, By Country
Figure 46: Europe Market Attractiveness Analysis, By Country
Figure 47: Europe Market Value Share Analysis, 2019E & 2029F, By Product Type
Figure 48: Europe Market Attractiveness Analysis, By Product Type
Figure 49: Europe Market Value Share Analysis 2019E & 2029F, By Indication
Figure 50: Europe Market Attractiveness Analysis, By Indication
Figure 51: Europe Market Value Share Analysis, 2019E & 2029F, By Sales Channel
Figure 52: Europe Market Attractiveness Analysis, By Sales Channel
Figure 53: South Asia Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 54: South Asia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 55: South Asia Market Value Share 2019E, By Product Type
Figure 56: South Asia Market Value Share 2019E, By Indication
Figure 57: South Asia Market Value Share 2019E, By Sales Channel
Figure 58: South Asia Market Value Share 2019E, By Country
Figure 59: South Asia Market Value Share Analysis 2019E & 2029F, By Country
Figure 60: South Asia Market Attractiveness Analysis, By Country
Figure 61: South Asia Market Value Share Analysis, 2019E & 2029F, By Product Type
Figure 62: South Asia Market Attractiveness Analysis, By Product Type
Figure 63: South Asia Market Value Share Analysis 2019E & 2029F, By Indication
Figure 64: South Asia Market Attractiveness Analysis, By Indication
Figure 65: South Asia Market Value Share Analysis, 2019E & 2029F, By Sales Channel
Figure 66: South Asia Market Attractiveness Analysis, By Sales Channel
Figure 67: East Asia Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 68: East Asia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 69: East Asia Market Value Share 2019E, By Product Type
Figure 70: East Asia Market Value Share 2019E, By Indication
Figure 71: East Asia Market Value Share 2019E, By Sales Channel
Figure 72: East Asia Market Value Share 2019E, By Country
Figure 73: East Asia Market Value Share Analysis 2019E & 2029F, By Country
Figure 74: East Asia Market Attractiveness Analysis, By Country
Figure 75: East Asia Market Value Share Analysis, 2019E & 2029F, By Product Type
Figure 76: East Asia Market Attractiveness Analysis, By Product Type
Figure 77: East Asia Market Value Share Analysis 2019E & 2029F, By Indication
Figure 78: East Asia Market Attractiveness Analysis, By Indication
Figure 79: East Asia Market Value Share Analysis, 2019E & 2029F, By Sales Channel
Figure 80: East Asia Market Attractiveness Analysis, By Sales Channel
Figure 81: Oceania Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 82: Oceania Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 83: Oceania Market Value Share 2019E, By Product Type
Figure 84: Oceania Market Value Share 2019E, By Indication
Figure 85: Oceania Market Value Share 2019E, By Sales Channel
Figure 86: Oceania Market Value Share 2019E, By Country
Figure 87: Oceania Market Value Share Analysis 2019E & 2029F, By Country
Figure 88: Oceania Market Attractiveness Analysis, By Country
Figure 89: Oceania Market Value Share Analysis, 2019E & 2029F, By Product Type
Figure 90: Oceania Market Attractiveness Analysis, By Product Type
Figure 91: Oceania Market Value Share Analysis 2019E & 2029F, By Indication
Figure 92: Oceania Market Attractiveness Analysis, By Indication
Figure 93: Oceania Market Value Share Analysis, 2019E & 2029F, By Sales Channel
Figure 94: Oceania Market Attractiveness Analysis, By Sales Channel
Figure 95: MEA Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 96: MEA Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 97: MEA Market Value Share 2019E, By Product Type
Figure 98: MEA Market Value Share 2019E, By Indication
Figure 99: MEA Market Value Share 2019E, By Sales Channel
Figure 100: MEA Market Value Share 2019E, By Country
Figure 101: MEA Market Value Share Analysis 2019E & 2029F, By Country
Figure 102: MEA Market Attractiveness Analysis, By Country
Figure 103: MEA Market Value Share Analysis, 2019E & 2029F, By Product Type
Figure 104: MEA Market Attractiveness Analysis, By Product Type
Figure 105: MEA Market Value Share Analysis 2019E & 2029F, By Indication
Figure 106: MEA Market Attractiveness Analysis, By Indication
Figure 107: MEA Market Value Share Analysis, 2019E & 2029F, By Sales Channel
Figure 108: MEA Market Attractiveness Analysis, By Sales Channel
Figure 109: Emerging countries Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 110: Emerging countries Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 to 2029
- FAQs -
Which company received FDA approval for generic Invanz injection in Carbapenem?
In June 2018, Aurobindo Pharma received FDA approval for generic Invanz injection.
What are the product type of Carbapenem-based Antibiotics Market?
Meropenem,Ertapenem,Doripenem,Panipenem,Tebipenem are the product types of Carbapenem-based Antibiotics Market.
Related Reports
Carbapenem-based Antibiotics Market